Raphael Lecomte
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- Antimicrobial Resistance in Staphylococcus
- SARS-CoV-2 and COVID-19 Research
- Epidemiology top 5%
- Infective Endocarditis Diagnosis and Management
Papers in
- Epidemiology 29
- Infective Endocarditis Diagnosis and Management 23
- Pneumocystis jirovecii pneumonia detection and treatment 3
-
- Antimicrobial Resistance in Staphylococcus 7
- COVID-19 Clinical Research Studies 4
- HIV/AIDS drug development and treatment 3
- Co-authors
- David Boutoille (15 shared papers)François Raffi (4 shared papers)Antoine Néel (3 shared papers)Giovanni Gautier (1 shared paper)Mathieu Artifoni (1 shared paper)Benjamin Jean Gaborit (11 shared papers)Paul Le Turnier (6 shared papers)Christine Sagan (2 shared papers)
In The Last Decade
Raphael Lecomte
57 papers receiving 1.8k citations
Raphael Lecomte's Hit Papers
Peers
Comparison fields: 5 of 94
- Infectious Diseases 698
- Epidemiology 915
- Internal Medicine 77
- Microbiology 14
- Sensory Systems 68
Countries citing papers authored by Raphael Lecomte
This map shows the geographic impact of Raphael Lecomte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raphael Lecomte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raphael Lecomte more than expected).
Fields of papers citing papers by Raphael Lecomte
This network shows the impact of papers produced by Raphael Lecomte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raphael Lecomte. The network helps show where Raphael Lecomte may publish in the future.
Co-authors
The 25 scholars most cited alongside Raphael Lecomte, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study Hit paper breakdown → | 2019 | 568 |
| 2 | 2020 | 202 | |
| 3 | 2021 | 195 | |
| 4 | 2020 | 159 | |
| 5 | 2019 | 53 | |
| 6 | 2024 | 53 | |
| 7 | 2022 | 52 | |
| 8 | 2020 | 50 | |
| 9 | 2020 | 49 | |
| 10 | 2019 | 48 | |
| 11 | 2018 | 26 | |
| 12 | 2023 | 26 | |
| 13 | 2020 | 25 | |
| 14 | 2022 | 25 | |
| 15 | 2020 | 22 | |
| 16 | 2022 | 22 | |
| 17 | 2018 | 21 | |
| 18 | 2023 | 21 | |
| 19 | 2020 | 20 | |
| 20 | 2020 | 19 |
About Raphael Lecomte
Raphael Lecomte is a scholar working on Epidemiology, Infectious Diseases, Surgery, Microbiology and Parasitology, having authored 65 papers that have together received 1.9k indexed citations. Recurring topics across this work include Infective Endocarditis Diagnosis and Management (23 papers), Orthopedic Infections and Treatments (10 papers), Antimicrobial Resistance in Staphylococcus (7 papers), COVID-19 Clinical Research Studies (4 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), HIV/AIDS drug development and treatment (3 papers), Streptococcal Infections and Treatments (3 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). The work is most often cited by research in Infectious Diseases (698 citations), Epidemiology (915 citations), Internal Medicine (77 citations), Microbiology (14 citations) and Sensory Systems (68 citations). Raphael Lecomte has collaborated with scholars based in France, Canada and Italy. Frequent co-authors include David Boutoille, François Raffi, Antoine Néel, Giovanni Gautier, Mathieu Artifoni, Benjamin Jean Gaborit, Paul Le Turnier, Christine Sagan, Emmanuel Canet and Ronan Bellouard. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Clinical Infectious Diseases, Clinical Microbiology and Infection, European Heart Journal and Annals of Intensive Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.